Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore practical methods to assign budgeting tasks fairly, prevent bottlenecks, and foster teamwork in money management.
18,314 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
In a hypothetical scenario, Gemini faces a class-action suit after pivoting to prediction markets. Investors wonder i...
A veteran figure in AI, nicknamed the 'godfather ai,' argues big tech prioritizes short-term profits over the endgame...
Insider activity can shed light on a company's future. This deep dive examines Perdoceo Education's $1.8 million insi...
A conflict over Iran threatens Asia's access to fertilizer and helium, risking farm yields and semiconductor supply c...
A global four-week contest stitches together AI personas, crypto rewards, and influencer intrigue. Here’s how fake in...
New market dynamics push five names into focus as AI, memory demand, and energy trends redefine winners and losers. A...
As drone-saturated battlefields rise, the world’s most advanced tanks drive a new era of defense spending. This repor...
Online rumors can spread faster than facts and hit your wallet hard. This guide shows how smears become mainstream, t...
Investors are eyeing AAR's AIR 2026 earnings call for clues on aftermarket demand, margins, and guidance. This articl...
A senior U.S. senator warns that college grad unemployment will surge as AI reshapes entry-level work, potentially up...
This original millionaire interview-style guide dives into the daily habits, smart choices, and concrete steps that h...